PTM Site Classification via Integrated In Silico Framework
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current drug design strategies face challenges in effectively targeting the functional diversity of protein post-translational modification (PTM) isoforms and the dynamics induced by PTMs, which limits the identification of druggable pockets and development of precision medicines.
Innovation Solution
An integrated in silico framework that combines sequence, structural topology, and dynamics features with protein modeling and machine learning is employed to characterize the functional context and druggability of PTM-associated pockets in proteins, specifically exploiting the allosteric potential of PTM sites.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional drug design strategies are used, then the development process is simpler and faster, but the ability to target functional diversity of PTM isoforms and identify druggable pockets is insufficient
Solution Approach 1:
The integrated framework is segmented into distinct functional modules: sequence analysis module, structural topology analysis module, dynamics simulation module, machine learning classification module, and pharmacophore identification module. Each module processes specific aspects of PTM site characterization independently, then integrates results to achieve comprehensive druggability assessment while maintaining manageable complexity
Solution Approach 2:
The framework employs universal computational tools and algorithms that can handle multiple types of PTMs (phosphorylation, glycosylation, ubiquitination, etc.) and various protein structures simultaneously. The machine learning model is trained on diverse datasets to recognize universal patterns across different PTM isoforms, enabling broad applicability without requiring separate specialized systems for each modification type
2Measurement precision
If comprehensive sequence, structural topology, and dynamics features are analyzed, then classification accuracy of PTM sites improves, but computational time and resources increase
Solution Approach 1:
The framework performs preliminary filtering and feature extraction by pre-processing sequences and structures to identify potential PTM sites before conducting comprehensive analysis. Pre-computed structural parameters and pre-trained machine learning models are used to quickly eliminate non-druggable sites, reducing the computational burden on subsequent detailed analysis steps
Solution Approach 2:
The framework employs dynamic sampling and adaptive analysis where the level of computational detail is adjusted based on initial screening results. Fast dynamic simulations are used for initial assessment, with full dynamic analysis reserved only for sites showing promise in preliminary screens, optimizing the balance between accuracy and computational cost
3Measurement precision
If machine learning modeling is applied to classify PTM sites, then identification of druggable pockets becomes more accurate, but the complexity of model training and validation increases
Solution Approach 1:
The framework uses intermediate feature representations and descriptor vectors that bridge the gap between complex protein structures and machine learning classification. These intermediate representations simplify the input data while preserving critical druggability information, making the learning problem more tractable without sacrificing accuracy
Solution Approach 2:
The machine learning model employs adjustable parameters and hyperparameters that can be optimized through systematic validation. The framework tests multiple model architectures and parameter configurations, selecting the optimal combination that achieves high accuracy while maintaining computational efficiency and interpretability
4Productivity
If the framework targets allosteric potential of PTM sites, then novel pharmacophores can be identified, but the difficulty of detecting and measuring allosteric interactions increases
Solution Approach 1:
The framework replaces direct experimental measurement of allosteric interactions with computational prediction methods. Molecular dynamics simulations and free energy calculations substitute for complex experimental assays, enabling in silico detection of allosteric sites and their druggability without requiring physical measurement of weak transient interactions
Data Source
AI summary
Novel systems and methods for drug design and screening exploiting dynamics of protein post-translational modifications are provided.